Trial intelligence / Profile preview

Tenofovir DF in Asian-American Adults With Chronic Hepatitis B

NCT00736190Phase 4Completed

Sponsor
Gilead Sciences
Start
Aug 2008
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Aug 2008; status: completed.

02

Drugs

tenofovir disoproxil fumarate
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT00736190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00736190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call